Voya Investment Management LLC Immuno Gen, Inc. Transaction History

Voya Investment Management LLC

$86.1 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $1.92 Million - $4.62 Million	154,215 Added 29.94%	669,351 $19.8 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $1.23 Million - $1.73 Million	86,946 Added 20.31%	515,136 $8.18 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $986,291 - $5.27 Million	-263,011 Reduced 38.05%	428,190 $8.08 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $135,723 - $181,951	-36,982 Reduced 5.08%	691,201 $2.65 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $1.38 Million - $1.92 Million	-304,318 Reduced 29.47%	728,183 $3.61 Million

Q3 2022 Mar 03, 2023	BUY	$4.48 - $6.47 $1.36 Million - $1.97 Million	304,318 Added 41.79%	1,032,501 $4.94 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $4.24 Million - $6.12 Million	946,412 Added 1099.34%	1,032,501 $4.94 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $11,525 - $21,075	3,659 Added 4.44%	86,089 $388,000
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $13,401 - $23,532	3,146 Added 3.97%	82,430 $392,000
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $1.8 Million - $2.85 Million	-379,385 Reduced 82.71%	79,284 $588,000
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $165,936 - $217,832	-33,055 Reduced 6.72%	458,669 $2.6 Million
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $104,984 - $155,935	-18,132 Reduced 3.56%	491,724 $3.24 Million
Q1 2021 May 17, 2021	SELL	$6.5 - $10.53 $437,918 - $709,427	-67,372 Reduced 11.67%	509,856 $4.13 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $1.91 Million - $3.96 Million	517,365 Added 864.25%	577,228 $3.72 Million
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $79,666 - $128,138	-23,996 Reduced 28.61%	59,863 $275,000
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $27,138 - $87,046	12,801 Added 18.01%	83,859 $286,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $25,447 - $65,598	11,310 Added 18.93%	71,058 $363,000
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $2.46 Million - $4.51 Million	-1,366,691 Reduced 95.81%	59,748 $130,000
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $1.94 Million - $4.77 Million	-806,282 Reduced 36.11%	1,426,439 $3.87 Million
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $753,706 - $1.86 Million	-191,296 Reduced 7.89%	2,232,721 $10.7 Million
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $4.94 Million - $6.47 Million	574,761 Added 31.08%	2,424,017 $23 Million
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $17.2 Million - $21.9 Million	1,805,412 Added 4117.81%	1,849,256 $18 Million
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $4,121 - $6,438	813 Added 1.89%	43,844 $281,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $232,367 - $364,472	43,031	43,031 $329,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account